4.5 Article

Diallyl disulfide improves lipid metabolism by inhibiting PCSK9 expression and increasing LDL uptake via PI3K/Akt-SREBP2 pathway in HepG2 cells

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Diallyl disulfide potentiates anti-obesity effect of green tea in high-fat/high-sucrose diet-induced obesity

Jaehoon Bae et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)

Article Integrative & Complementary Medicine

Fermented Garlic Ameliorates Hypercholesterolemia and Inhibits Platelet Activation

Muhammad Irfan et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

Review Medicine, Research & Experimental

Role of PCSK9 in lipid metabolism and atherosclerosis

Xiao-Long Lin et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Primary Health Care

Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors

Muhammed Shahreyar et al.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2018)

Article Gastroenterology & Hepatology

A Novel Role for CRTC2 in Hepatic Cholesterol Synthesis Through SREBP-2

Yujie Li et al.

HEPATOLOGY (2017)

Article Chemistry, Medicinal

Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans

Yuan-Lin Guo et al.

LETTERS IN DRUG DESIGN & DISCOVERY (2017)

Article Biochemistry & Molecular Biology

Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway

Xiaofeng Ma et al.

LIPIDS IN HEALTH AND DISEASE (2017)

Article Cardiac & Cardiovascular Systems

Executive Summary: Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association

Dariush Mozaffarian et al.

CIRCULATION (2016)

Review Nutrition & Dietetics

Lipid-modifying effects of nutraceuticals: An evidence-based approach

Amirhossein Sahebkar et al.

NUTRITION (2016)

Article Integrative & Complementary Medicine

Antioxidant and Hypolipidemic Potential of Aged Garlic Extract and Its Constituent, S-Allyl Cysteine, in Rats

Syed Mohammed Basheeruddin Asdaq

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)

Review Cell Biology

Recent insights into the cellular biology of atherosclerosis

Ira Tabas et al.

JOURNAL OF CELL BIOLOGY (2015)

Review Cardiac & Cardiovascular Systems

PCSK9: A Key Modulator of Cardiovascular Health

Nabil G. Seidah et al.

CIRCULATION RESEARCH (2014)

Article Biochemistry & Molecular Biology

Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats

Yan Zhang et al.

LIPIDS IN HEALTH AND DISEASE (2014)

Article Pharmacology & Pharmacy

Short-Term Impact of Low-Dose Atorvastatin on Serum Proprotein Convertase Subtilisin/Kexin Type 9

Yuan-Lin Guo et al.

CLINICAL DRUG INVESTIGATION (2013)

Article Biochemistry & Molecular Biology

Rapid effects of different lipid-lowering drugs on PCSK9 in humans

Jun Liu et al.

CLINICAL LIPIDOLOGY (2013)

Article Multidisciplinary Sciences

Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1

Jenny E. Kanter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Multidisciplinary Sciences

Progress and challenges in translating the biology of atherosclerosis

Peter Libby et al.

NATURE (2011)

Review Endocrinology & Metabolism

The Akt-SREBP nexus: cell signaling meets lipid metabolism

James R. Krycer et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)

Article Biochemistry & Molecular Biology

Inflammation stimulates the expression of PCSK9

Kenneth R. Feingold et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Medicine, Research & Experimental

Inflammation may be a bridge connecting hypertension and atherosclerosis

JJ Li et al.

MEDICAL HYPOTHESES (2005)